A patchwork of regulations challenges manufacturers and distributors in the US
Click here to download FRR's 2018 Definitive Guide to State Licensing
Multi-Indication Drug Branding in Today’s Pharmaceutical Industry
July 2nd 2025As drug development increasingly targets multiple indications, pharma companies must make strategic branding decisions—balancing regulatory requirements, market dynamics, and patient safety—to choose between single-brand or multi-brand approaches.